Skip to main content
Elsevier

Immunotherapy for Autoimmune Disorders

Innovations and Insights

  • 1st Edition - November 1, 2026
  • Latest edition
  • Editors: Arun Kumar Singh, Nagaraju Bandaru, Vasso Apostolopoulos, Ashutosh Pareek, Murali M. Yallapu
  • Language: English

Immunotherapy for Autoimmune Disorders: Innovations and Insights revolutionizes the therapeutic paradigm for autoimmune illnesses, offering new perspectives over traditional medica… Read more

Description

Immunotherapy for Autoimmune Disorders: Innovations and Insights revolutionizes the therapeutic paradigm for autoimmune illnesses, offering new perspectives over traditional medication therapies. This complete and accessible resource examines how immunotherapy teaches the immune system to detect and fight targeted cells, enhancing the body's immune response by providing additional components to strengthen its defense mechanisms. The book covers a wide range of topics, including the pathophysiology, diagnosis, and classification of autoimmune diseases, the immunopathogenesis of these disorders, and the development and application of monoclonal antibodies. It explores immune checkpoint inhibitors, T-cell modulation therapies, cytokine targeting therapies, B-cell depletion strategies, and more.

Additionally, it addresses immunomodulatory agents, small molecules, personalized immunotherapy approaches, and the application of immunotherapeutic strategies for specific autoimmune diseases. Future directions and emerging therapies, as well as regulatory and ethical considerations, are also discussed. This is essential reading for medical professionals, researchers, and students seeking to learn about immunotherapy as an alternative approach to treating autoimmune disorders.

Key features

  • Provides in-depth knowledge on the pathophysiology, diagnosis, and treatment of autoimmune diseases
  • Explores cutting-edge immunotherapy techniques and their applications in autoimmune disorder treatments
  • Bridges the gap between scientific research and clinical practice for better patient management
  • Enhances academic and clinical research through detailed case studies and clinical trial findings
  • Fosters collaboration among medical professionals, researchers, and policymakers for innovative treatment solutions

Readership

Medical professionals, and researchers directly involved in the diagnosis, treatment, and management of autoimmune disorders; pharmaceutical and biotech professionals in immunotherapy

Table of contents

1. Overview of Autoimmune Disorders and Immunotherapy

2. The Immunopathogenesis of Autoimmune Diseases

3. Monoclonal Antibodies in Autoimmune Disease Treatment

4. Immune Checkpoint Inhibitors in Autoimmunity

5. T-cell Modulation Therapies

6. Cytokine Targeting Therapies

7. B-cell Depletion Strategies

8. Adoptive Cell Transfer and Regulatory T Cells

9. Immunomodulatory Agents and Small Molecules

10. Personalized Immunotherapy Approaches

11. Immunotherapy in Specific Autoimmune Diseases

12. Future Directions and Emerging Therapies in Immunotherapy for Autoimmune Disorders

13. Regulatory and Ethical Considerations in Autoimmunotherapy Application

Product details

  • Edition: 1
  • Latest edition
  • Published: November 1, 2026
  • Language: English

About the editors

AS

Arun Kumar Singh

Arun Kumar Singh is Assistant Professor in the Department of Pharmacy at Vivekanand Global University, India. His teaching and research activities span pharmaceutical sciences and a range of interdisciplinary fields, including nanoformulation, cancer biology, artificial intelligence, machine learning, blockchain technology, the Internet of Things, big data analytics, and neuroscience. He has contributed to scholarly publishing through authorship and editorial work and has participated in research and academic initiatives that integrate emerging technologies with healthcare and pharmaceutical applications. His interests focus on advancing innovative approaches to drug delivery, biomedical research, and technology-enabled solutions for healthcare challenges.

Affiliations and expertise
Assistant Professor, University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, Tehsil Kharar, Distt. Mohali, Punjab, India

NB

Nagaraju Bandaru

Nagarau Bandaru completed his B. Pharm (2011) and M. Pharm (2013) in Pharmacology from Shri Vishnu College of Pharmacy, Bhimavaram, and earned his PhD (2021) from Acharya Nagarjuna University, Guntur, AP, India. With 10 years of teaching experience, he has published 48 research and review papers, 6 patents, and 8 books. He has presented at numerous national and international seminars and conferences and delivered guest lectures at various Indian universities. His accolades include the Best Teacher award from K L University, Best Researcher, Young Scientist, and Distinguished Alumni awards from Shri Vishnu College of Pharmacy. He has received fellowships such as GPAT AICTE and CSIR NEIST summer research fellowship. His research focuses on Neuropharmacology. He has guided many M. Pharm and B. Pharm student projects and is an approved Ph.D. supervisor at Sandip University and K L University. He has also completed 4 NGO projects and secured funded grants.
Affiliations and expertise
Associate Professor; HOD, Department of Pharmacology, Sandip University School of Pharmaceutical Sciences, India

VA

Vasso Apostolopoulos

Professor Vasso Apostolopoulos is a Distinguished Professor at RMIT University, Australia. She received her PhD in immunology in 1995 from the University of Melbourne and the Advanced Certificate in Protein Crystallography from Birkbeck College, University of London. Professor Vasso Apostolopoulos is a world-renowned researcher who has been recognized with over 100 awards for the outstanding results of her research. She has published over 500 research publications, 8 books, and 33 book chapters, is a sought-after keynote speaker at conferences, is an inventor on 21 patents, and has over 22,000 citations.

Affiliations and expertise
Distinguished Professor, School of Health and Biomedical Sciences, RMIT University School of Health and Biomedical Sciences

AP

Ashutosh Pareek

Ashutosh Pareek is Professor at Banasthali Vidyapith, India, with expertise in neuropharmacology and advanced drug delivery systems. His research focuses on therapeutic strategies for neurodegenerative disorders, cancer, autoimmune diseases, and related health conditions, with particular interest in the development of innovative drug delivery approaches for bioactive and immunomodulatory compounds. Dr. Pareek leads research initiatives in these areas and collaborates with national and international funding agencies on projects that advance pharmaceutical science and translational research. He has contributed extensively to the scientific literature through scholarly publications, books, patents, and research mentorship. In addition, he serves on editorial and peer-review activities for international journals in pharmacology and oncology, supporting the dissemination and evaluation of research across the biomedical sciences.

Affiliations and expertise
Professor, Department of Pharmacy, Banasthali Vidyapith, Banasthali, Tonk, Rajasthan, India

MY

Murali M. Yallapu

Dr. Murali Yallapu is a tenured Professor at the University of Texas Rio Grande Valley's School of Medicine, specializing in Immunology, Microbiology,Toxicology and Oncology and a member of the South Texas Center of Excellence in Cancer Research. Dr. Yallapu received the "Prof. A. Kameswara Rao's Gold Medal-1999" and completed postdoctoral training in materials science, drug delivery, nanomedicine, and cancer biology at institutions including the Cleveland Clinic and the University of Nebraska Medical Center. Before joining UTRGV, he was an Assistant Professor at the University of Tennessee Health Science Center. Dr. Yallapu serves on editorial boards for various journals related to drug delivery, nanotechnology, and cancer, and is an ad-hoc reviewer for the NIH and other funding agencies. He has published over 190 peer-reviewed articles and reviews. His current research primarily focuses on the development of nanomaterials for improved therapeutic potential of clinical drug(s) and developing new constructs for biomedical applications. Additionally, through Cancer Immunology Institute, he is working to generate safe and effective nanoformulations for cancer immunotherapy.

Affiliations and expertise
Director, RCMI Research Core Co-Director, CPRIT-ICRC Program Coordinator, CPRIT-TREC, School of Medicine, University of Texas Rio Grande Valley, USA